Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

European shares dip as US-Iran tensions weigh on sentiment
21 Apr 2026

European shares dip as US-Iran tensions weigh on sentiment

* Thales shares drop after Q1 sales miss analyst forecasts

Germany risks missing out on new drugs, AstraZeneca CEO tells paper
21 Apr 2026

Germany risks missing out on new drugs, AstraZeneca CEO tells paper

FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily ​Handelsblatt on ⁠Tuesday that Germany risks missing out ​on new drugs that the Anglo-Swe...

AstraZeneca says Ultomiris meets primary endpoint in phase III trial
21 Apr 2026

AstraZeneca says Ultomiris meets primary endpoint in phase III trial

(Alliance News) - AstraZeneca PLC on Tuesday reported positive findings from trial results studying its kidney disease treatment, Ultomiris.

AstraZeneca receives positive high level results from Phase III I CAN trial
21 Apr 2026

AstraZeneca receives positive high level results from Phase III I CAN trial

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that high‑level results from an interim analysis of its Phase III I CAN trial showed Ul...

UK stocks slip as uncertainty over US-Iran ceasefire lifts oil prices
20 Apr 2026

UK stocks slip as uncertainty over US-Iran ceasefire lifts oil prices

April 20 (Reuters) - The ​UK's main ⁠stock indexes dipped on Monday ​in broad-based losses as fears that the U.S.-Iran ceasefire could collapse weighe...

AstraZeneca's Tozorakimab meets primary endpoint in "pivotal" trial
20 Apr 2026

AstraZeneca's Tozorakimab meets primary endpoint in "pivotal" trial

(Alliance News) - AstraZeneca PLC on Monday reported positive phase three results for its monoclonal antibody, Tozorakimab, meeting its primary endpoi...

London stocks rise on Middle East peace optimism
16 Apr 2026

London stocks rise on Middle East peace optimism

April 16 (Reuters) - UK's ​main ‌stock indexes edged higher on Thursday, supported by strength in ⁠materials and financials, as hopes grew ⁠for a reso...

Stegra secures $1.7 billion, shoring up one of Europe's last big green steel bets
14 Apr 2026

Stegra secures $1.7 billion, shoring up one of Europe's last big green steel bets

* Stegra secures funding to complete ​hydrogen-based steel plant